SHR-1905

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

AsthmaChronic Rhinosinusitis With Nasal Polyps

161 competitors in Asthma

#DrugCompanyPhaseTrials

1

SHR-1905

Guangdong Hengrui Pharmaceutical Co., Ltd

Phase 3

32

Celexa

AbbVie

Preclinical

13

Solu-Medrol

MMassachusetts Eye and Ear Infirmary

Preclinical

14

DUPIXENT

Regeneron

Preclinical

15

Paracetamol

GSK

Preclinical

16

Blood Withdrawn

Emergent BioSolutions

Preclinical

17

Blood Collection

AAssistance Publique - Hôpitaux de Paris

Preclinical

18

Lexapro

SShirley Ryan AbilityLab

Preclinical

19

Biological Drug

UUniversitaire Ziekenhuizen KU Leuven

Preclinical

110

Guanidine Hydrochloride

CCidara Therapeutics Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)

Preclinical

1Show 17 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Asthma3 trials

Pharmacokinetics, Pharmacodynamics, Safety, and Preliminary Efficacy of Subcutaneous Injection of SHR-1905 in Adolescent Asthmatic Subjects - an Open-label, Single-dose Phase II Clinical Study

Completed·Guangdong Hengrui Pharmaceutical Co., Ltd·Phase 2·NCT06786455·9 enrolled

A Trial of SHR-1905 in Subjects With Severe Uncontrolled Asthma

Recruiting·Guangdong Hengrui Pharmaceutical Co., Ltd·Phase 3·NCT07098403·408 enrolled

A Multicentre, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Study to Evaluate the Efficacy and Safety of SHR-1905 in Subjects With Severe Uncontrolled Asthma.

Completed·Shanghai Hengrui Pharmaceutical Co., Ltd.·Phase 2·NCT05593250·260 enrolled

Chronic Rhinosinusitis With Nasal Polyps2 trials

Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps

Recruiting·Guangdong Hengrui Pharmaceutical Co., Ltd·Phase 3·NCT07132827·280 enrolled

A Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Phase 2 Efficacy and Safety Study of SHR-1905 in Patiens With Chronic Rhinosinusitis With Nasal Polyps

Completed·Guangdong Hengrui Pharmaceutical Co., Ltd·Phase 2·NCT05891483·114 enrolled

Trial1 trial

A Trial of SHR-1905 in Healthy Subjects

Completed·AAtridia Pty Ltd.·Phase 1·NCT04800263·50 enrolled

Atopic Dermatitis1 trial

A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis

Recruiting·Guangdong Hengrui Pharmaceutical Co., Ltd·Phase 2·NCT07211542·75 enrolled

Details

Drug Info

Related News